CCXI logo

ChemoCentryx (CCXI) Shareholders Equity

CCXI Annual Shareholders Equity

$286.12 M
-$99.49 M-25.80%

31 December 2021

CCXI Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CCXI Quarterly Shareholders Equity

$236.53 M
-$22.19 M-8.58%

30 June 2022

CCXI Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CCXI Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-25.8%-28.4%
3 y3 years+1841.4%+231.0%
5 y5 years+261.0%+478.1%

CCXI Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall time-25.8%-43.8%

ChemoCentryx Shareholders Equity History

DateAnnualQuarterly
June 2022
-
$236.53 M(-8.6%)
Mar 2022
-
$258.72 M(-9.6%)
Dec 2021
$286.12 M(-25.8%)
$286.12 M(-9.4%)
Sept 2021
-
$315.89 M(-4.4%)
June 2021
-
$330.27 M(-8.5%)
Mar 2021
-
$361.00 M(-6.4%)
Dec 2020
$385.61 M(+484.3%)
$385.61 M(-4.7%)
Sept 2020
-
$404.82 M(-3.9%)
June 2020
-
$421.14 M(+600.0%)
Mar 2020
-
$60.16 M(-8.8%)
Dec 2019
$66.00 M(+347.8%)
$66.00 M(+6.7%)
Sept 2019
-
$61.86 M(-13.4%)
June 2019
-
$71.46 M(-11.4%)
Mar 2019
-
$80.64 M(+447.2%)
Dec 2018
$14.74 M(-81.4%)
$14.74 M(-31.4%)
Sept 2018
-
$21.47 M(-25.7%)
June 2018
-
$28.90 M(+13.2%)
Mar 2018
-
$25.53 M(-67.8%)
Dec 2017
$79.27 M(+58.9%)
$79.27 M(+112.5%)
Sept 2017
-
$37.30 M(-8.8%)
June 2017
-
$40.91 M(-11.7%)
Mar 2017
-
$46.32 M(-7.1%)
Dec 2016
$49.89 M
$49.89 M(-8.2%)
DateAnnualQuarterly
Sept 2016
-
$54.35 M(-8.7%)
June 2016
-
$59.53 M(-0.5%)
Mar 2016
-
$59.83 M(-17.5%)
Dec 2015
$72.51 M(-33.2%)
$72.51 M(-11.0%)
Sept 2015
-
$81.50 M(-10.3%)
June 2015
-
$90.91 M(-8.6%)
Mar 2015
-
$99.41 M(-8.5%)
Dec 2014
$108.61 M(-25.3%)
$108.61 M(-8.4%)
Sept 2014
-
$118.51 M(-7.0%)
June 2014
-
$127.43 M(-7.1%)
Mar 2014
-
$137.19 M(-5.6%)
Dec 2013
$145.31 M(+31.7%)
$145.31 M(-5.1%)
Sept 2013
-
$153.18 M(-4.6%)
June 2013
-
$160.55 M(+55.4%)
Mar 2013
-
$103.28 M(-6.4%)
Dec 2012
$110.35 M(+45.2%)
$110.35 M(-6.5%)
Sept 2012
-
$118.00 M(-6.6%)
June 2012
-
$126.41 M(-7.3%)
Mar 2012
-
$136.38 M(+79.5%)
Dec 2011
$76.00 M(-1.0%)
$76.00 M(+33.4%)
Sept 2011
-
$56.95 M(-12.2%)
June 2011
-
$64.89 M(-15.5%)
Dec 2010
$76.77 M(-0.7%)
$76.77 M
Dec 2009
$77.30 M
-

FAQ

  • What is ChemoCentryx annual stockholders equity?
  • What is the all time high annual shareholders equity for ChemoCentryx?
  • What is ChemoCentryx annual shareholders equity year-on-year change?
  • What is ChemoCentryx quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for ChemoCentryx?
  • What is ChemoCentryx quarterly shareholders equity year-on-year change?

What is ChemoCentryx annual stockholders equity?

The current annual shareholders equity of CCXI is $286.12 M

What is the all time high annual shareholders equity for ChemoCentryx?

ChemoCentryx all-time high annual stockholders equity is $385.61 M

What is ChemoCentryx annual shareholders equity year-on-year change?

Over the past year, CCXI annual stockholders equity has changed by -$99.49 M (-25.80%)

What is ChemoCentryx quarterly stockholders equity?

The current quarterly shareholders equity of CCXI is $236.53 M

What is the all time high quarterly shareholders equity for ChemoCentryx?

ChemoCentryx all-time high quarterly stockholders equity is $421.14 M

What is ChemoCentryx quarterly shareholders equity year-on-year change?

Over the past year, CCXI quarterly stockholders equity has changed by -$93.74 M (-28.38%)